Back to search
Patency of the Ductus Arteriosus Acetaminophen Extreme Prematurity
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Patency of the Ductus Arteriosus Acetaminophen Extreme Prematurity trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Patency of the Ductus Arteriosus Acetaminophen Extreme Prematurity trials you may qualify forThe ductus arteriosus (DA) is a large channel connecting the main pulmonary trunk with the descending aorta. In extremely preterm infants, the DA frequently fai…
Patent ductus arteriosus (PDA), the most common cardiovascular complication of prematurity, is associated with higher mortality and morbidities in extremely low…
TREOCAPA is a Phase II/III European Multicentre study concerning the prophylactic treatment by Acetaminophen of extremely preterm infant during the first five d…
Patent ductus arteriosus (PDA) is the most common cardiovascular problem that develops in preterm infants. Persistent PDA may result in higher rates of death, c…
In the present trial, early, intravenous paracetamol is compared to placebo in extremely premature or low birth weight infants in order to evaluate the effect o…